Skip to content
← Back to this collection

PUBLICATIONS · 12775737

Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2003 Jun 1
First author
Seymour JF

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Seymour JF
      type
      Author
    2. name
      Pro B
      type
      Author
    3. name
      Fuller LM
      type
      Author
    4. name
      Manning JT
      type
      Author
    5. name
      Hagemeister FB
      type
      Author
    6. name
      Romaguera J
      type
      Author
    7. name
      Rodriguez MA
      type
      Author
    8. name
      Ha CS
      type
      Author
    9. name
      Smith TL
      type
      Author
    10. name
      Ayala A
      type
      Author
    11. name
      Hess M
      type
      Author
    12. name
      Cox JD
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Seymour JF
      type
      Author
    2. name
      Pro B
      type
      Author
    3. name
      Fuller LM
      type
      Author
    4. name
      Manning JT
      type
      Author
    5. name
      Hagemeister FB
      type
      Author
    6. name
      Romaguera J
      type
      Author
    7. name
      Rodriguez MA
      type
      Author
    8. name
      Ha CS
      type
      Author
    9. name
      Smith TL
      type
      Author
    10. name
      Ayala A
      type
      Author
    11. name
      Hess M
      type
      Author
    12. name
      Cox JD
      type
      Author
    bibliography ids
    1. nci-bib-6a19d022fc10456e9fe4c0b3
    book metadata
    content sha256
    7f8bfdac17b710f72535fbc4d7e01506df9ab79f76be0335599b277b6d74d7b0
    document type
    citation
    dois
    1. 10.1200/JCO.2003.07.111
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:12775737
    immutable id
    pubmed:12775737@7f8bfdac17b710f72535fbc4d7e01506df9ab79f76be0335599b277b6d74d7b0
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    Source null
    issn print
    0732-183X
    issue
    11
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    2115-22
    volume
    21
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      12775737
      provenance
      batch id
      2d0158fe73b50bb1a4bf
      provider
      NCBI PubMed ESummary
      record sha256
      4a3b68b1778bb0f886c49a6d36217a938c04e69eb12753e742acf43a07a1889a
      response sha256
      d46de44782d91ef4394e88a69f82b1ee22148e8c4cf1534eb36c80479345e70e
      retrieved at
      2026-09-09T23:45:50.935339+00:00
      publication date
      display
      2003 Jun 1
      precision
      day
      year
      2003
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Review
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/12775737/
      title
      Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.

      Preserved source evidence · Independent clinical review pending · Not medical advice